Cargando…
Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers
Gastrointestinal (GI) cancers account for a large proportion of cancer deaths worldwide and pose a major public health challenge. Immunotherapy is considered to be one of the prominent and successful approaches in cancer treatment in recent years. Among them, immune checkpoint inhibitor (ICI) therap...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790411/ https://www.ncbi.nlm.nih.gov/pubmed/35116101 http://dx.doi.org/10.4251/wjgo.v14.i1.19 |